Advanced search
Publication Cover
International Journal of Hyperthermia Volume 36, 2019 - Issue sup1: Special Issue: Thermal Therapy and Immunotherapy at the Crossroads of New Discovery. Guest Editors: Sharon Evans and Steven Fiering
Submit an article Journal homepage
1,964
Views
15
CrossRef citations to date
0
Altmetric
Articles

Immunogenetic effects of low dose (CEM43 30) magnetic nanoparticle hyperthermia and radiation in melanoma cells

Kayla E. A. DuvalThayer School of Engineering, Dartmouth College, Hanover, NH, USA; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-5854-3735View further author information
ORCID Icon,
Nicholas A. VerniceGeisel School of Medicine, Dartmouth College, Hanover, NH, USAView further author information
,
Robert J. WagnerGeisel School of Medicine, Dartmouth College, Hanover, NH, USAView further author information
,
Steven N. FieringGeisel School of Medicine, Dartmouth College, Hanover, NH, USAView further author information
,
James D. PetrykGeisel School of Medicine, Dartmouth College, Hanover, NH, USAView further author information
,
Gabriela J. LowryGeisel School of Medicine, Dartmouth College, Hanover, NH, USAView further author information
,
Steven S. TauGeisel School of Medicine, Dartmouth College, Hanover, NH, USAView further author information
,
John YinGeisel School of Medicine, Dartmouth College, Hanover, NH, USAView further author information
,
Georgia R. HoudeGeisel School of Medicine, Dartmouth College, Hanover, NH, USAView further author information
,
Aneeq S. ChaudhryGeisel School of Medicine, Dartmouth College, Hanover, NH, USAView further author information
&
P. Jack HoopesThayer School of Engineering, Dartmouth College, Hanover, NH, USA; ;Geisel School of Medicine, Dartmouth College, Hanover, NH, USAView further author information
 show all
Pages 37-46 | Received 16 May 2019, Accepted 31 May 2019, Published online: 03 Dec 2019

References

  • Chen W, Zhang J. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J Nanosci Nanotechnol. 2016;6:1159–1166.
  • Horsman MR, Overgaard J, Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol. 2007;19:418–426.
  • Kalbasi A, June CH, Haas N, et al. Radiation and immunotherapy: a synergistic combination. J Clin Invest. 2013;123:2756–2763.
  • Frey B, Weiss EM, Rubner Y, et al. Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperth. 2012;28:528–542.
  • Multhoff G. Heat shock proteins in immunity. Handb Exp Pharmacol. 2006;(172):279–304.
  • Goto Y, Arigami T, Kitago M, et al. Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors. Mol Cancer Ther. 2008;7:3642–3653.
  • He W, Liu Q, Wang L, et al. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol. 2007;44:2850–2859.
  • Huang B, Zhao J, Li H, et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res. 2005;65:5009–5014.
  • Lopez-Bergami P. The role of mitogen- and stress-activated protein kinase pathways in melanoma. Pigment Cell Melanoma Res. 2011;24:902–921.
  • Keuling AM, Andrew SE, Tron VA. Inhibition of p38 MAPK enhances ABT-737-induced cell death in melanoma cell lines: novel regulation of PUMA. Pigment Cell Melanoma Res. 2010;23:430–440.
  • Estrada Y, Dong J, Ossowski L. Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation. Pigment Cell Melanoma Res. 2009;22:66–76.
  • Lasithiotakis KG, Sinnberg TW, Schittek B, et al. Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells. J Invest Dermatol. 2008;128:2013–2023.
  • Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene. 2004;23:2838–2849.
  • Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35:495–516.
  • Tamura RE, de Vasconcellos JF, Sarkar D, et al. GADD45 proteins: central players in tumorigenesis. Curr Mol Med. 2012;12:634–651.
  • Cretu A, Sha X, Tront J, et al. Stress sensor Gadd45 genes as therapeutic targets in cancer. Cancer Ther. 2009;7:268–276.
  • Altomonte M, Gloghini A, Bertola G, et al. Differential expression of cell adhesion molecules CD54/CDlla and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Cancer Res. 1993;53:3343–3348.
  • Webb DS, Mostowski HS, Gerrard TL. Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis. J Immunol. 1991;146:3682–3686.
  • Karni-Schmidt O, Lokshin M, Prives C. The roles of MDM2 and MDMX in cancer. Annu Rev Pathol Mech Dis. 2016;11:617–644.
  • Onel K, Cordon-Cardo C. MDM2 and prognosis. Mol Cancer Res. 2004;2:1–8.
  • Melnikova VO, Bolshakov SV, Walker C, et al. Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines. Oncogene. 2004;23:2347–2356.
  • Karbowniczek M, Spittle CS, Morrison T, et al. mTOR is activated in the majority of malignant melanomas. J Invest Dermatol. 2008;128:980–987.
  • Kuo PT, Zeng Z, Salim N, et al. The role of CXCR3 and its chemokine ligands in skin disease and cancer. Front Med. 2018;5:271.
  • Tokunaga R, Zhang W, Naseem M, et al. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation-a target for novel cancer therapy. Cancer Treat Rev. 2018;63:40–47.
  • Yu L, Chen S. Toll-like receptors expressed in tumor cells: targets for therapy. Cancer Immunol Immunother. 2008;57:1271–1278.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.